Thomas Berg

Research interests

Publications

• Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

  Annals of Oncology · 2024 · https://doi.org/10.1016/j.annonc.2024.02.005

• A global research priority agenda to advance public health responses to fatty liver disease

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.04.035

• Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

  The Lancet Oncology · 2023 · https://doi.org/10.1016/s1470-2045(23)00469-2

• Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.10.043

• A global research priority agenda to advance public health responses to fatty liver disease

  Journal of Hepatology · 2023 · https://doi.org/10.1016/j.jhep.2023.04.035

• Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.11.006

• An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.09.025

• Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

  Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01495-3

• Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.11.024

• PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.11.019

• The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.06.013

• Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)33041-7

• Update of the statements on biology and clinical impact of occult hepatitis B virus infection

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.03.034

• Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.11.003

• Experimental evidence of mechanical lumpy skin disease virus transmission by Stomoxys calcitrans biting flies and Haematopota spp. horseflies

  Scientific Reports · 2019 · https://doi.org/10.1038/s41598-019-56605-6

• EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.03.021

• Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.07.012

• Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

  Clinical Gastroenterology and Hepatology · 2016 · https://doi.org/10.1016/j.cgh.2015.12.042

• A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

  Nature Genetics · 2015 · https://doi.org/10.1038/ng.3417

• Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1512612

• The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

  Journal of Viral Hepatitis · 2014 · https://doi.org/10.1111/jvh.12248

• ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1402869

• Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

  Gastroenterology · 2014 · https://doi.org/10.1053/j.gastro.2014.04.022

• Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

  Hepatology · 2010 · https://doi.org/10.1002/hep.24017

• Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

  Gastroenterology · 2010 · https://doi.org/10.1053/j.gastro.2009.12.056

• Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

  Hepatology · 2010 · https://doi.org/10.1002/hep.23952

• IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

  Nature Genetics · 2009 · https://doi.org/10.1038/ng.447

• Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

  Hepatology · 2009 · https://doi.org/10.1002/hep.23246

• Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy

  Gastroenterology · 2009 · https://doi.org/10.1053/j.gastro.2009.01.039

• Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa043470

• Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C

  Gastroenterology · 2005 · https://doi.org/10.1053/j.gastro.2005.05.008

• Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy

  Hepatology · 2003 · https://doi.org/10.1053/jhep.2003.50106

Current projects

No projects listed.